ArticleExperimental & molecular medicine2023

The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy.

Hui-Ching Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.